Article
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers.
Nature communications - 10 Aug 2018
Gettinger S N, Choi J, Mani N, Sanmamed M F, Datar I, Sowell Ryan, Du Victor Y, Kaftan E, Goldberg S, Dong W, Zelterman D, Politi K, Kavathas P, Kaech S, Yu X, Zhao H, Schlessinger J, Lifton R, Rimm D L, Chen L, Herbst R S, Schalper K A
Abstract excerpt
The biological determinants of sensitivity and resistance to immune checkpoint blockers are not completely understood. To elucidate the role of intratumoral T-cells and their association with the tumor genomic landscape, we perform paired whole exome DNA sequencing and multiplexed quantitative immunofluorescence (QIF) in pre-treatment samples from non-small cell lung carcinoma (NSCLC) patients treated with PD-1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
